{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:43:10Z","timestamp":1792446190998,"version":"4.5.0"},"reference-count":121,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2022.13451","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T06:17:55Z","timestamp":1659939475000},"source":"Crossref","is-referenced-by-count":12,"title":["Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in <i>TP53<\/i>, <i>MDM2<\/i> and <i>ATM<\/i> genes in Sardinian women"],"prefix":"10.3892","volume":"24","author":[{"given":"Matteo","family":"Floris","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Surgery and Pharmacy, University of Sassari, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Pira","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Surgery and Pharmacy, University of Sassari, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Castiglia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Idda","sequence":"additional","affiliation":[{"name":"Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Cagliari, I-09121 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maristella","family":"Steri","sequence":"additional","affiliation":[{"name":"Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Cagliari, I-09121 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Miglio","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Piana","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cossu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Azara","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Arru","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Surgery and Pharmacy, University of Sassari, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Deiana","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Surgery and Pharmacy, University of Sassari, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Putzu","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Azienda Ospedaliera Universitaria, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Sanna","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Azienda Ospedaliera Universitaria, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciriaco","family":"Carru","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Surgery and Pharmacy, University of Sassari, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Serra","sequence":"additional","affiliation":[{"name":"Unit of Occupational Medicine, Azienda Ospedaliera Universitaria, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bisail","sequence":"additional","affiliation":[{"name":"Lega Italiana per la Lotta contro i Tumori, Sassari, I-07100 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Muroni","sequence":"additional","affiliation":[{"name":"Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Cagliari, I-09121 Sardinia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"key20220923112536_b1-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20220923112536_b2-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/0969141318780152","article-title":"The effect of mammography screening regimen on incidence-based breast cancer mortality","volume":"25","author":"Yaffe","year":"2018","journal-title":"J Med Screen"},{"key":"key20220923112536_b3-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00001622-199911000-00003","article-title":"Epidemiology, prevention, and early detection of breast cancer","volume":"11","author":"Alberg","year":"1999","journal-title":"Curr Opin Oncol"},{"key":"key20220923112536_b4-ol-24-04-13451","first-page":"151","article-title":"Epidemiological characteristics of and risk factors for breast cancer in the world","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"key20220923112536_b5-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.annepidem.2005.02.015","article-title":"Hormonal and body-size factors in relation to breast cancer risk: A prospective study of 11,889 women in a low-incidence area","volume":"16","author":"Wu","year":"2006","journal-title":"Ann Epidemiol"},{"key":"key20220923112536_b6-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s11684-009-0080-z","article-title":"Meta-analysis of the risk factors of breast cancer concerning reproductive factors and oral contraceptive use","volume":"3","author":"Dai","year":"2009","journal-title":"Front Med China"},{"key":"key20220923112536_b7-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"12941","DOI":"10.1007\/s13277-016-5168-x","article-title":"Breast cancer epidemic in the early twenty-first century: Evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures","volume":"37","author":"Golubnitschaja","year":"2016","journal-title":"Tumor Biol"},{"key":"key20220923112536_b8-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1349-7006.2005.00010.x","article-title":"Impact of menstrual and reproductive factors on breast cancer risk in Japan: Results of the JACC study","volume":"96","author":"Tamakoshi","year":"2005","journal-title":"Cancer Sci"},{"key":"key20220923112536_b9-ol-24-04-13451","first-page":"241","article-title":"A Review of modifiable risk factors in young women for the prevention of breast cancer","volume":"13","author":"Daly","year":"2021","journal-title":"Breast cancer (Dove Med Press)"},{"key":"key20220923112536_b10-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"536","DOI":"10.7150\/ijms.23402","article-title":"miRNA-135b contributes to triple negative breast cancer molecular heterogeneity: Different expression profile in basal-like versus non-basal-like phenotypes","volume":"15","author":"Uva","year":"2018","journal-title":"Int J Med Sci"},{"key":"key20220923112536_b11-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"key20220923112536_b12-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.3390\/cancers13163953","article-title":"Risks and Function of breast cancer susceptibility alleles","volume":"13","author":"Dalivandan","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20220923112536_b13-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1582-4934.2005.tb00350.x","article-title":"Understanding breast cancer risk-where do we stand in 2005?","volume":"9","author":"Dumitrescu","year":"2005","journal-title":"J Cell Mol Med"},{"key":"key20220923112536_b14-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"110635","DOI":"10.18632\/oncotarget.22372","article-title":"Single nucleotide polymorphisms and cancer susceptibility","volume":"8","author":"Deng","year":"2017","journal-title":"Oncotarget"},{"key":"key20220923112536_b15-ol-24-04-13451","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1392-9","article-title":"Genome-wide association study of susceptibility loci for breast cancer in Sardinian population","volume":"15","author":"Palomba","year":"2015","journal-title":"BMC Cancer"},{"key":"key20220923112536_b16-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1470-2045(11)70084-5","article-title":"Genetic variants associated with breast-cancer risk","volume":"12","author":"Narod","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20220923112536_b17-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"key":"key20220923112536_b18-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.7150\/ijms.32162","article-title":"Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in breast cancer: A sardinian preliminary case-control study","volume":"16","author":"Castiglia","year":"2019","journal-title":"Int J Med Sci"},{"key":"key20220923112536_b19-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12885-020-06749-w","article-title":"MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: A case-control study in a population from North Sardinia","volume":"20","author":"Floris","year":"2020","journal-title":"BMC Cancer"},{"key":"key20220923112536_b20-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10549-010-0861-8","article-title":"Mutations and polymorphic BRCA variants transmission in breast cancer familial members","volume":"125","author":"Pilato","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"key20220923112536_b21-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: Growing ever more complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20220923112536_b22-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/humu.22556","article-title":"Analysis of TP53 mutation status in human cancer cell lines: A reassessment","volume":"35","author":"Leroy","year":"2014","journal-title":"Hum Mutat"},{"key":"key20220923112536_b23-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: Mining complete cancer genomes in the catalogue of somatic mutations in cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"key20220923112536_b24-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJM199310283291807","article-title":"Clinical implications of the p53 tumor-suppressor gene","volume":"329","author":"Harris","year":"1993","journal-title":"N Engl J Med"},{"key":"key20220923112536_b25-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"Vogelstein","year":"2004","journal-title":"Nat Med"},{"key":"key20220923112536_b26-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"16202","DOI":"10.1074\/jbc.275.21.16202","article-title":"Death signal-induced localization of p53 protein to mitochondria: A potential role in apoptotic signaling","volume":"275","author":"Marchenko","year":"2000","journal-title":"J Biol Chem"},{"key":"key20220923112536_b27-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1126\/science.1114297","article-title":"PUMA couples the nuclear and cytoplasmic proapoptotic function of p53","volume":"309","author":"Chipuk","year":"2005","journal-title":"Science"},{"key":"key20220923112536_b28-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cell.2004.11.022","article-title":"A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans","volume":"119","author":"Bond","year":"2004","journal-title":"Cell"},{"key":"key20220923112536_b29-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/ijms20030509","article-title":"Association of the MDM2 SNP285 and SNP309 genetic variants with the risk, age at onset and prognosis of breast cancer in Central European women: A hospital-based case-control study","volume":"20","author":"Miedl","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20220923112536_b30-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"210","DOI":"10.20892\/j.issn.2095-3941.2018.0022","article-title":"ATM in breast and brain tumors: A comprehensive review","volume":"15","author":"Estiar","year":"2018","journal-title":"Cancer Biol Med"},{"key":"key20220923112536_b31-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/humu.10174","article-title":"TP53 and breast cancer","volume":"21","author":"B\u00f8rresen-Dale","year":"2003","journal-title":"Hum Mutat"},{"key":"key20220923112536_b32-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"a001032","DOI":"10.1101\/cshperspect.a001032","article-title":"Single-nucleotide polymorphisms in the p53 signaling pathway","volume":"2","author":"Grochola","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20220923112536_b33-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrc2584","article-title":"p53 polymorphisms: Cancer implications","volume":"9","author":"Whibley","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20220923112536_b34-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000143400","article-title":"Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancer","volume":"29","author":"Vannini","year":"2008","journal-title":"Tumor Biol"},{"key":"key20220923112536_b35-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/bcr1682","article-title":"Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients","volume":"9","author":"Toyama","year":"2007","journal-title":"Breast Cancer Res"},{"key":"key20220923112536_b36-ol-24-04-13451","first-page":"1703","article-title":"Simple sequence repeat polymorphism within the p53 gene","volume":"8","author":"Lazar","year":"1993","journal-title":"Oncogene"},{"key":"key20220923112536_b37-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1089\/dna.1995.14.983","article-title":"A Novel Polymorphism in Intron 6 of the Human p53 Gene: A possible association with cancer predisposition and susceptibility","volume":"14","author":"Peller","year":"1995","journal-title":"DNA Cell Biol"},{"key":"key20220923112536_b38-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"9584","DOI":"10.1158\/0008-5472.CAN-07-0738","article-title":"Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium","volume":"67","author":"Schmidt","year":"2007","journal-title":"Cancer Res"},{"key":"key20220923112536_b39-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1186\/2193-1801-3-749","article-title":"Association of the TP53 codon 72 polymorphism and breast cancer risk: A meta-analysis","volume":"3","author":"Gon\u00e7alves","year":"2014","journal-title":"Springerplus"},{"key":"key20220923112536_b40-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.1007\/s11033-012-1800-z","article-title":"Individual and combined effects of MDM2 SNP309 and TP53 Arg72Pro on breast cancer risk: An updated meta-analysis","volume":"39","author":"Cheng","year":"2012","journal-title":"Mol Biol Rep"},{"key":"key20220923112536_b41-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ng1093","article-title":"The codon 72 polymorphic variants of p53 have markedly different apoptotic potential","volume":"33","author":"Dumont","year":"2003","journal-title":"Nat Genet"},{"key":"key20220923112536_b42-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1128\/MCB.19.2.1092","article-title":"Two polymorphic variants of wild-type p53 differ biochemically and biologically","volume":"19","author":"Thomas","year":"1999","journal-title":"Mol Cell Biol"},{"key":"key20220923112536_b43-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/ijc.11548","article-title":"P53 polymorphic variants at codon 72 exert different effects on cell cycle progression","volume":"108","author":"Pim","year":"2004","journal-title":"Int J Cancer"},{"key":"key20220923112536_b44-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1038\/sj.onc.1209405","article-title":"Trp53-dependent DNA-repair is affected by the codon 72 polymorphism","volume":"25","author":"Siddique","year":"2006","journal-title":"Oncogene"},{"key":"key20220923112536_b45-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum Mutat"},{"key":"key20220923112536_b46-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-cancerbio-050216-121926","article-title":"P53: Multiple facets of a rubik's cube","volume":"1","author":"Zhang","year":"2017","journal-title":"Annu Rev Cancer Biol"},{"key":"key20220923112536_b47-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1093\/carcin\/bgs232","article-title":"The rebel angel: Mutant p53 as the driving oncogene in breast cancer","volume":"33","author":"Walerych","year":"2012","journal-title":"Carcinogenesis"},{"key":"key20220923112536_b48-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"e0141763","DOI":"10.1371\/journal.pone.0141763","article-title":"Analysis of PIK3CA mutations and activation pathways in triple negative breast cancer","volume":"10","author":"Cossu-Rocca","year":"2015","journal-title":"PLoS One"},{"key":"key20220923112536_b49-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.tranon.2017.07.006","article-title":"The functional roles of the MDM2 splice variants P2-MDM2-10 and MDM2-\u22065 in breast cancer cells","volume":"10","author":"Huun","year":"2017","journal-title":"Transl Oncol"},{"key":"key20220923112536_b50-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1568009053332627","article-title":"MDM2 is a central node in the p53 pathway: 12 years and counting","volume":"5","author":"Bond","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"key20220923112536_b51-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s12885-017-3762-y","article-title":"The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females","volume":"17","author":"Isakova","year":"2017","journal-title":"BMC Cancer"},{"key":"key20220923112536_b52-ol-24-04-13451","first-page":"269","article-title":"Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: A meta-analysis based on 9,788 cases and 11,195 controls","volume":"10","author":"Gao","year":"2014","journal-title":"Ther Clin Risk Manag"},{"key":"key20220923112536_b53-ol-24-04-13451","first-page":"1059","article-title":"Significant association of the MDM2 T309G polymorphism with breast cancer risk in a Turkish Population","volume":"19","author":"Yilmaz","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20220923112536_b54-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/carcin\/bgm191","article-title":"MDM2 SNP309 and cancer risk: A combined analysis","volume":"28","author":"Wilkening","year":"2007","journal-title":"Carcinogenesis"},{"key":"key20220923112536_b55-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/336577a0","article-title":"Localization of an ataxia-telangiectasia gene to chromosome 11q22-23","volume":"336","author":"Gatti","year":"1988","journal-title":"Nature"},{"key":"key20220923112536_b56-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.cell.2008.05.020","article-title":"SnapShot: p53 posttranslational modifications","volume":"133","author":"Kruse","year":"2008","journal-title":"Cell"},{"key":"key20220923112536_b57-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1038\/sj.emboj.7600812","article-title":"ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage","volume":"24","author":"Chen","year":"2005","journal-title":"EMBO J"},{"key":"key20220923112536_b58-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"7741","DOI":"10.1038\/sj.onc.1210872","article-title":"Activation and regulation of ATM kinase activity in response to DNA double-strand breaks","volume":"26","author":"Lee","year":"2007","journal-title":"Oncogene"},{"key":"key20220923112536_b59-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2407-8-117","article-title":"Association of common ATM variants with familial breast cancer in a South American population","volume":"8","author":"Gonz\u00e1lez-Hormaz\u00e1bal","year":"2008","journal-title":"BMC Cancer"},{"key":"key20220923112536_b60-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ijc.20996","article-title":"Association of common ATM polymorphism with bilateral breast cancer","volume":"116","author":"Heikkinen","year":"2005","journal-title":"Int J Cancer"},{"key":"key20220923112536_b61-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"807466","DOI":"10.3389\/fgene.2022.807466","article-title":"Association between the TP53 polymorphisms and breast cancer risk: An updated meta-analysis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Genet"},{"key":"key20220923112536_b62-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12881-020-01072-4","article-title":"p.Arg72Pro polymorphism of P53 and breast cancer risk: A meta-analysis of case-control studies","volume":"21","author":"Diakite","year":"2020","journal-title":"BMC Med Genet"},{"key":"key20220923112536_b63-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12881-020-01072-4","article-title":"Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis","volume":"21","author":"Diakite","year":"2020","journal-title":"BMC Med Genet"},{"key":"key20220923112536_b64-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"e23529","DOI":"10.1002\/jcla.23529","article-title":"A case-control study on the SNP309T \u2192 G and 40-bp Del1518 of the MDM2 gene and a systematic review for MDM2 polymorphisms in the patients with breast cancer","volume":"34","author":"Jalilvand","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"key20220923112536_b65-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"760","DOI":"10.51620\/0869-2084-2021-66-12-760-767","article-title":"Clinical significance of gene polymorphisms for hereditary predisposition to breast and ovarian cancer (review of literature)","volume":"66","author":"Vodolazhsky","year":"2021","journal-title":"Klin Lab Diagn"},{"key":"key20220923112536_b66-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/s41588-018-0215-8","article-title":"Genomic history of the Sardinian population","volume":"50","author":"Chiang","year":"2018","journal-title":"Nat Genet"},{"key":"key20220923112536_b67-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/humu.20283","article-title":"A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers","volume":"27","author":"Osorio","year":"2006","journal-title":"Hum Mutat"},{"key":"key20220923112536_b68-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/bioinformatics\/btm025","article-title":"SNPassoc: An R package to perform whole genome association studies","volume":"23","author":"Gonz\u00e1lez","year":"2007","journal-title":"Bioinformatics"},{"key":"key20220923112536_b69-ol-24-04-13451","first-page":"176","article-title":"Basic methods of analysis","volume-title":"Case-Control Studies: Design, Conduct, Analysis: Design, Conduct, Analysis","author":"Schlesselman","year":"1982"},{"key":"key20220923112536_b70-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nat"},{"key":"key20220923112536_b71-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cdp.2008.06.003","article-title":"The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases","volume":"32","author":"De Vecchi","year":"2008","journal-title":"Cancer Detect Prev"},{"key":"key20220923112536_b72-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.7314\/APJCP.2015.16.7.2971","article-title":"Lack of influence of TP53 Arg72Pro and 16bp duplication polymorphisms on risk of breast cancer in iran","volume":"16","author":"Gohari-Lasaki","year":"2015","journal-title":"Asian Pacific J Cancer Prev"},{"key":"key20220923112536_b73-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.gene.2015.05.048","article-title":"Effect of TP53 16-bp and \u03b2-TrCP 9-bp INS\/DEL polymorphisms in relation to risk of breast cancer","volume":"568","author":"Eskandari-Nasab","year":"2015","journal-title":"Gene"},{"key":"key20220923112536_b74-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2407-8-32","article-title":"Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer","volume":"8","author":"Costa","year":"2008","journal-title":"BMC Cancer"},{"key":"key20220923112536_b75-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000489852","article-title":"The 72Pro variant of the tumor protein 53 is associated with an increased breast cancer risk in the Moroccan Population","volume":"85","author":"Ayoubi","year":"2018","journal-title":"Pathobiology"},{"key":"key20220923112536_b76-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/carcin\/bgq018","article-title":"Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: A meta-analysis","volume":"31","author":"Hu","year":"2010","journal-title":"Carcinogenesis"},{"key":"key20220923112536_b77-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12253-008-9129-6","article-title":"Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer","volume":"15","author":"Akkiprik","year":"2009","journal-title":"Pathol Oncol Res"},{"key":"key20220923112536_b78-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1582-4934.2008.00634.x","article-title":"Polymorphisms in p53 and the p53 pathway: Roles in cancer susceptibility and response to treatment","volume":"13","author":"Hrstka","year":"2009","journal-title":"J Cell Mol Med"},{"key":"key20220923112536_b79-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40001-018-0345-6","article-title":"No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: New evidence from a population-based case-control investigation","volume":"23","author":"Hao","year":"2018","journal-title":"Eur J Med Res"},{"key":"key20220923112536_b80-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10549-018-5039-9","article-title":"The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer","volume":"173","author":"Morten","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"key20220923112536_b81-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0140-6736(96)90569-3","article-title":"P53 polymorphism in ovarian and breast cancer","volume":"347","author":"Campbell","year":"1996","journal-title":"Lancet"},{"key":"key20220923112536_b82-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/bjc.1998.108","article-title":"TP53 intron 6 polymorphism and the risk of ovarian and breast cancer","volume":"77","author":"Mavridou","year":"1998","journal-title":"Br J Cancer"},{"key":"key20220923112536_b83-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/aje\/kws394","article-title":"Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: A systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer","volume":"177","author":"Dahabreh","year":"2013","journal-title":"Am J Epidemiol"},{"key":"key20220923112536_b84-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10549-013-2615-x","article-title":"Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility","volume":"140","author":"Liu","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"key20220923112536_b85-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.7314\/APJCP.2014.15.16.6871","article-title":"TP53 polymorphisms in sporadic North Indian breast cancer patients","volume":"15","author":"Sharma","year":"2014","journal-title":"Asian Pacific J Cancer Prev"},{"key":"key20220923112536_b86-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"e0134463","DOI":"10.1371\/journal.pone.0134463","article-title":"Genotype and haplotype analyses of TP53 gene in breast cancer patients: Association with risk and clinical outcomes","volume":"10","author":"Vymetalkova","year":"2015","journal-title":"PLoS One"},{"key":"key20220923112536_b87-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1093\/carcin\/bgu206","article-title":"Impact of G-quadruplex structures and intronic polymorphisms rs17878362 and rs1642785 on basal and ionizing radiation-induced expression of alternative p53 transcripts","volume":"35","author":"Perriaud","year":"2014","journal-title":"Carcinogenesis"},{"key":"key20220923112536_b88-ol-24-04-13451","first-page":"1653","article-title":"Splicing mutations of the p53 gene in human hepatocellular carcinoma","volume":"53","author":"Lai","year":"1993","journal-title":"Cancer Res"},{"key":"key20220923112536_b89-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1172\/JCI114710","article-title":"Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer","volume":"86","author":"Takahashi","year":"1990","journal-title":"J Clin Invest"},{"key":"key20220923112536_b90-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/sj.onc.1207305","article-title":"A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA","volume":"23","author":"Gemignani","year":"2004","journal-title":"Oncogene"},{"key":"key20220923112536_b91-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0169-5002(00)00188-4","article-title":"Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer","volume":"31","author":"Biro\u0161","year":"2001","journal-title":"Lung Cancer"},{"key":"key20220923112536_b92-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1158\/0008-5472.CAN-06-0180","article-title":"MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner","volume":"66","author":"Bond","year":"2006","journal-title":"Cancer Res"},{"key":"key20220923112536_b93-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10552-005-1540-7","article-title":"ATM Polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States)","volume":"16","author":"Jones","year":"2005","journal-title":"Cancer Causes Control"},{"key":"key20220923112536_b94-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1086\/321296","article-title":"Global analysis of ATM polymorphism reveals significant functional constraint","volume":"69","author":"Thorstenson","year":"2001","journal-title":"Am J Hum Genet"},{"key":"key20220923112536_b95-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1471-2407-6-209","article-title":"ATM variants and cancer risk in breast cancer patients from Southern Finland","volume":"6","author":"Tommiska","year":"2006","journal-title":"BMC Cancer"},{"key":"key20220923112536_b96-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1186\/bcr1623","article-title":"Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: A population-based case-control and follow-up study","volume":"8","author":"Einarsd\u00f3ttir","year":"2006","journal-title":"Breast Cancer Res"},{"key":"key20220923112536_b97-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.mrfmmm.2004.04.020","article-title":"ATM signaling and genomic stability in response to DNA damage","volume":"569","author":"Lavin","year":"2005","journal-title":"Mutat Res"},{"key":"key20220923112536_b98-ol-24-04-13451","first-page":"271","article-title":"Breast Cancer","volume":"5","author":"Veronesi","year":"2005","journal-title":"Discov Med"},{"key":"key20220923112536_b99-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0140-6736(02)09454-0","article-title":"Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease","volume":"360","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2002","journal-title":"Lancet"},{"key":"key20220923112536_b100-ol-24-04-13451","article-title":"IARC Monographs on the Identification of Carcinogenic Hazards to Humans, List of classifications by cancer sites with sufficient or limited evidence in humans","author":"World Health Organization (WHO)","journal-title":"IARC Monographs Volumes 1\u2013132"},{"key":"key20220923112536_b101-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-013-2531-0","article-title":"Reproductive factors and the risk of breast cancer in old age: A Norwegian cohort study","volume":"139","author":"Horn","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"key20220923112536_b102-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s10552-013-0243-8","article-title":"Do reproductive and hormonal risk factors for breast cancer associate with attendance at mammography screening?","volume":"24","author":"Lagerlund","year":"2013","journal-title":"Cancer Causes Control"},{"key":"key20220923112536_b103-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1038\/sj.bjc.6690306","article-title":"Risk factors for breast cancer in nulliparous women","volume":"79","author":"Fioretti","year":"1999","journal-title":"Br J Cancer"},{"key":"key20220923112536_b104-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40659-017-0140-9","article-title":"Awareness and current knowledge of breast cancer","volume":"50","author":"Akram","year":"2017","journal-title":"Biol Res"},{"key":"key20220923112536_b105-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1023\/A:1008961931534","article-title":"Weight change and risk of postmenopausal breast cancer (United States)","volume":"11","author":"Trentham-Dietz","year":"2000","journal-title":"Cancer Causes Control"},{"key":"key20220923112536_b106-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s12889-018-5357-1","article-title":"Connecting the dots between breast cancer, obesity and alcohol consumption in middle-aged women: Ecological and case control studies","volume":"18","author":"Miller","year":"2018","journal-title":"BMC Public Health"},{"key":"key20220923112536_b107-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.7314\/APJCP.2013.14.4.2207","article-title":"Mechanics behind breast cancer prevention-focus on obesity, exercise and dietary fat","volume":"14","author":"Alegre","year":"2013","journal-title":"Asian Pacific J Cancer Prev"},{"key":"key20220923112536_b108-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10549-011-1716-7","article-title":"Physical activity and breast cancer survival: An epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1","volume":"133","author":"Zeng","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"key20220923112536_b109-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejca.2010.09.005","article-title":"Molecular mechanisms of leptin and adiponectin in breast cancer","volume":"47","author":"Jard\u00e9","year":"2011","journal-title":"Eur J Cancer"},{"key":"key20220923112536_b110-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"S277","DOI":"10.1093\/ajcn\/45.1.277","article-title":"Adipose tissue as a source of hormones","volume":"45","author":"Siiteri","year":"1987","journal-title":"Am J Clin Nutr"},{"key":"key20220923112536_b111-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.3390\/ijms20215364","article-title":"Molecular links between central obesity and breast cancer","volume":"20","author":"Zimta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20220923112536_b112-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-642-04231-7_2","article-title":"Physical activity and breast cancer prevention","volume":"186","author":"Lynch","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"key20220923112536_b113-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s10549-012-2396-7","article-title":"Physical activity and risk of breast cancer: A meta-analysis of prospective studies","volume":"137","author":"Wu","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"key20220923112536_b114-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/NCC.0000000000000580","article-title":"A meta-analysis of the association between physical activity and breast cancer mortality","volume":"42","author":"Lee","year":"2019","journal-title":"Cancer Nurs"},{"key":"key20220923112536_b115-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jama.290.10.1331","article-title":"Recreational physical activity and the risk of breast cancer in postmenopausal women: The women's health initiative cohort study","volume":"290","author":"McTiernan","year":"2003","journal-title":"JAMA"},{"key":"key20220923112536_b116-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/00008469-200402000-00002","article-title":"Physical activity in adolescence and young adulthood and breast cancer risk: A quantitative review","volume":"13","author":"Lagerros","year":"2004","journal-title":"Eur J Cancer Prev"},{"key":"key20220923112536_b117-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/bcr921","article-title":"Towards an integrated model for breast cancer etiology: The lifelong interplay of genes, lifestyle, and hormones","volume":"6","author":"Hankinson","year":"2004","journal-title":"Breast Cancer Res"},{"key":"key20220923112536_b118-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"key":"key20220923112536_b119-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","article-title":"Epidemiology of breast cancer","volume":"2","author":"Key","year":"2001","journal-title":"Lancet Oncol"},{"key":"key20220923112536_b120-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","article-title":"Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease","volume":"358","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2001","journal-title":"Lancet"},{"key":"key20220923112536_b121-ol-24-04-13451","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","article-title":"ABC of breast diseases: Breast cancer-Epidemiology, risk factors, and genetics","volume":"321","author":"McPherson","year":"2000","journal-title":"BMJ"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T08:26:47Z","timestamp":1663921607000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2022.13451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":121,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,8,8]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2022.13451","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]},"article-number":"331"}}